Steven F. Bellon

Insider Reports History

Entity
Individual
Location
500 Technology Square, Suite 700, Cambridge, MA
Signature
/s /Tara Maduri, Attorney-in-Fact for Steven F. Bellon
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven F. Bellon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Chief Scientific Officer Common Stock 102K $969K $9.50 Sep 9, 2024 Direct
Foghorn Therapeutics Inc. Chief Scientific Officer Stock Option (right to buy) 110K $337K $3.06 Jan 24, 2024 Direct

Insider Reports Filed by Steven F. Bellon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FHTX Foghorn Therapeutics Inc. Sep 9, 2024 1 -$190K 4 Sep 11, 2024 Chief Scientific Officer
FHTX Foghorn Therapeutics Inc. Jan 24, 2024 1 $337K 4 Jan 25, 2024 Chief Scientific Officer
FHTX Foghorn Therapeutics Inc. Jan 26, 2023 1 $0 4 Jan 30, 2023 Chief Scientific Officer
FHTX Foghorn Therapeutics Inc. Aug 11, 2022 2 $6.91K 4 Aug 15, 2022 Chief Scientific Officer
FHTX Foghorn Therapeutics Inc. May 25, 2022 4 $14.3K 4 May 27, 2022 Chief Scientific Officer
FHTX Foghorn Therapeutics Inc. Jan 26, 2022 1 $0 4 Jan 28, 2022 Chief Scientific Officer
FHTX Foghorn Therapeutics Inc. Jan 10, 2022 0 $0 3 Jan 11, 2022 Chief Scientific Officer